Makers Laboratories standalone returns to quarterly profit
Key highlights
- Makers Laboratories reported a standalone profit after tax of Rs 65.68 lakh for the quarter ended September 30, 2026.
- Standalone revenue from operations rose to Rs 13.92 crore in September 2026 from Rs 10.19 crore in the preceding quarter.
- The first-half standalone loss narrowed to Rs 41.82 lakh from Rs 58.39 lakh a year earlier.
- Standalone operating cash flow was negative Rs 34.05 lakh for the half year ended September 30, 2026.
powered by IRIS

Makers Laboratories Limited returned to a standalone profit of Rs 65.68 lakh in the quarter ended September 30, 2026, reversing losses of Rs 107.50 lakh in the preceding quarter and Rs 31.19 lakh a year earlier, although its first-half standalone result remained a Rs 41.82 lakh loss.
Know Makers Laboratories inside out
Results, valuation, peers and who's buying, in one view.
How did Makers Laboratories return to standalone profit in September 2026?
Makers Laboratories made a Rs 65.68 lakh profit after tax in the September 2026 quarter, compared with a Rs 107.50 lakh loss in the June 2026 quarter and a Rs 31.19 lakh loss in the September 2025 quarter. Profit before tax was Rs 88.47 lakh, against losses before tax of Rs 125.72 lakh sequentially and Rs 40.91 lakh a year earlier. The result contained no exceptional items, leaving the reported pre-tax outcome to reflect the ordinary standalone business before tax.
Revenue from operations rose to Rs 13.92 crore in the September quarter from Rs 10.19 crore in June and Rs 12.64 crore in the year-earlier quarter. Total income reached Rs 14.45 crore, including Rs 52.87 lakh of other income, versus Rs 10.26 crore in the June quarter and Rs 13.17 crore a year earlier. Other income was near the Rs 52.67 lakh reported in September 2025, while operating revenue increased in both comparisons.
Total expenses were Rs 13.57 crore in the September quarter, below total income of Rs 14.45 crore and producing the Rs 88.47 lakh pre-tax profit. Expenses had been Rs 11.52 crore in June, but exceeded that quarter's Rs 10.26 crore total income, resulting in a pre-tax loss. Compared with September 2025, expenses were nearly unchanged from Rs 13.58 crore while total income increased by Rs 1.28 crore.
What changed in Makers Laboratories' first-half standalone results?
Makers Laboratories remained loss-making for the six months ended September 30, 2026, recording a Rs 41.82 lakh loss after tax, but this was narrower than the Rs 58.39 lakh loss in the corresponding six months of 2025. The first-half pre-tax loss narrowed to Rs 37.25 lakh from Rs 70.86 lakh. The September-quarter profit therefore did not fully offset the June-quarter loss, but reduced the cumulative deficit from a year earlier.
First-half revenue from operations fell to Rs 24.11 crore from Rs 26.37 crore a year earlier, a reduction of Rs 2.26 crore. Total income similarly decreased to Rs 24.71 crore from Rs 26.93 crore. Total expenses declined more sharply, to Rs 25.08 crore from Rs 27.64 crore, a reduction of Rs 2.56 crore, which coincided with the narrower pre-tax loss despite lower revenue.
Makers Laboratories has one reportable standalone segment, Pharmaceuticals, under Indian Accounting Standard 108, or Ind AS 108. It therefore did not disclose separate product, geographical or business-line figures within the Rs 24.11 crore first-half operating revenue. September-quarter earnings per share, not annualised, was Rs 1.11, compared with a loss per share of Rs 1.82 in June and a loss per share of Rs 0.53 in September 2025.
The Board approved the unaudited standalone results on November 4, 2026, after review by its Audit Committee. The statutory auditors completed a limited review and issued an unmodified report, according to the results notes. That review covers the quarter and half year ended September 30, 2026 rather than an audit opinion on the financial statements.
Got a follow-up? Ask IRIS
What do Makers Laboratories' cash flow and balance sheet figures show?
Makers Laboratories reported net cash used in operating activities of Rs 34.05 lakh for the half year ended September 30, 2026, although this was less than the Rs 3.71 crore outflow in the prior-year half. Cash generated from operations was negative Rs 14.06 lakh after operating profit before working-capital changes of Rs 71.79 lakh. Net income tax paid of Rs 19.99 lakh took operating cash flow further into negative territory.
Working capital absorbed cash in several lines during the six-month period. Inventory increased by Rs 2.50 crore and trade receivables increased by Rs 1.02 crore, while other assets increased by Rs 69.27 lakh. These movements were partly offset by a Rs 2.58 crore increase in other liabilities, a Rs 48.33 lakh increase in trade payables and a Rs 16.34 lakh increase in other financial liabilities.
Total standalone assets were Rs 76.59 crore at September 30, 2026, compared with Rs 73.54 crore at March 31, 2026. Inventory rose to Rs 13.14 crore from Rs 10.64 crore and trade receivables rose to Rs 6.96 crore from Rs 5.97 crore. Cash and cash equivalents increased to Rs 4.98 lakh from Rs 1.71 lakh after investing activities generated Rs 33.92 lakh and financing activities generated Rs 3.40 lakh during the half year.
The increase in cash was Rs 3.27 lakh in the half year ended September 30, 2026, compared with an increase of Rs 4.84 lakh in the corresponding 2025 period. Investing inflow decreased from Rs 43.92 lakh a year earlier, while financing inflow declined from Rs 3.32 crore. The lower financing inflow reflected net short-term borrowing proceeds of Rs 31.78 lakh, compared with Rs 3.56 crore in the preceding year's half.
Equity stood at Rs 54.01 crore at September 30, down from Rs 54.43 crore at March 31, as other equity declined to Rs 48.11 crore from Rs 48.53 crore; share capital remained Rs 5.90 crore. Current borrowings increased to Rs 3.02 crore from Rs 2.70 crore. Trade payables due to entities other than micro and small enterprises rose to Rs 6.76 crore from Rs 5.16 crore, while payables due to micro and small enterprises fell to Rs 1.29 crore from Rs 2.40 crore.
Conclusion
Makers Laboratories' September-quarter standalone result returned to profit on Rs 13.92 crore of operating revenue, with total expenses of Rs 13.57 crore below total income of Rs 14.45 crore. The first-half loss narrowed to Rs 41.82 lakh from Rs 58.39 lakh despite a Rs 2.26 crore decline in operating revenue, but the half year still recorded an operating cash outflow of Rs 34.05 lakh.
The unresolved points are whether the Pharmaceuticals segment can maintain a quarterly profit after the Rs 107.50 lakh June loss, and whether working-capital movements reverse. Inventory was Rs 13.14 crore and receivables Rs 6.96 crore at September 30, 2026, both above March 31 levels, while current borrowings had increased to Rs 3.02 crore.


